Showing 5171-5180 of 5956 results for "".
- The Lancet Withdraws Major Hydroxychloroquine Studyhttps://modernod.com/news/the-lancet-withdraws-controversial-hydroxychloroquine-study/2477866/A major study in the Lancet that suggested hydroxychloroquine was associated with higher rates of ventricular arrhythmia and death in COVID-19 patients has been retracted. The multinational registry analysis, published in the Lancet on May 22, included nearly 15,000 peopl
- SightGlass Vision Granted CE Mark for Eyeglasses That Slow Myopia Progression in Childrenhttps://modernod.com/news/sightglass-vision-granted-ce-mark-for-novel-eyeglasses-that-slow-myopia-progression-in-children/2477859/SightGlass Vision announced it has achieved CE Mark approval for its first product – novel eyeglasses designed to slow the progression of myopia in children. The approval allows the SightGlass Vision to commercialize its suite of Diffusion Optics Technology (DOT) products across the EU,
- Lasik Vision Institute, TLC Laser Eye Center Operator Files for Bankruptcyhttps://modernod.com/news/lasik-vision-institute-tlc-laser-eye-center-operator-files-for-bankruptcy/2477856/Vision Group Holdings, the management company behind two leading LASIK surgery brands, filed for bankruptcy protection and launched a sale process aimed at placing the business into new hands as its surgical centers reopen, according to a Wall Street Journal
- Re-vana Therapeutics Raises $3.25 Million in Pre-Series A Financinghttps://modernod.com/news/re-vana-therapeutics-raises-3-25-million-in-pre-series-a-financing/2477857/Re-Vana Therapeutics, a privately-held specialty therapeutic and drug delivery company developing sustained-release therapeutics for significant sight-threatening ocular diseases, announced that it has closed $3.25 mi
- Lilly Begins World’s First Human Study of Antibody to Treat COVID-19https://modernod.com/news/lilly-begins-worlds-first-human-study-of-antibody-to-treat-covid-19/2477853/Eli Lilly said that the first patients have been dosed in a phase 1 trial investigating the experimental antibody LY-CoV555 for the treatment of COVID-19. The company, which is developing the drug with partner AbCellera, noted that the move marks the world’s first study of a potential antib
- Ocugen to Discontinue Phase 3 oGVHD Trialhttps://modernod.com/news/ocugen-to-discontinue-phase-3-ogvhd-trial/2477849/Ocugen announced the decision to discontinue the phase 3 trial of OCU300 for ocular Graft vs. Host Disease (oGVHD). The decision to stop the trial is based on results of a pre-planned interim sample size analysis conducted by an independent data monitoring committee, which indicated
- Johnson & Johnson Vision Appoints Erin McEachren as Regional Vice President, Surgical, EMEAhttps://modernod.com/news/johnson-johnson-vision-appoints-erin-mceachren-as-regional-vice-president-surgical-emea/2477847/Johnson & Johnson Vision has appointed Erin McEachren to the position of Regional Vice President for Johnson & Johnson Surgical Vision, EMEA. In this role, Ms. McEachren will lead Johnson & Johnson’s high-performance surgical vision team to address the unmet needs of patients and eye
- In-Person ESCRS and Euretina Meetings Cancelled; Virtual Meetings Plannedhttps://modernod.com/news/escrs-and-euretina-meetings-cancelled-virtual-meetings-planned/2477843/Due to the COVID-19 pandemic, the in-person ESCRS and Euretina meetings, scheduled to take place in Amsterdam in October, have been cancelled. Instead, the 38th Congress of the ESCRS and the 20th Euretina Congress will be held in a virtual format. In a joint letter to their memberships, ES
- A New Law in Laser Physics Could Make Eye Surgery Simplerhttps://modernod.com/news/a-new-law-in-laser-physics-could-make-eye-surgery-simpler/2477830/Scientists have developed a new type of laser that can deliver high amounts of energy in very short bursts of time, with potential applications in eye and heart surgery or the engineering of delicate materials, according to a
- U.S. Lawmakers Unveil Bold $100 Billion Plan to Remake NSFhttps://modernod.com/news/u-s-lawmakers-unveil-bold-100-billion-plan-to-remake-nsf/2477829/The National Science Foundation (NSF) would get a sweeping remake—including a new name, a huge infusion of cash, and responsibility for maintaining U.S. global leadership in innovation—under bipartisan bills that have just been introduced in both houses of Congress, according to a